The role of obesity and type 2 diabetes mellitus in the development of male obesity-associated secondary hypogonadism

Clinical Endocrinology

Volumn 78, Issue 3, 2013, Pages 330-337

  Saboor Aftab, S A ^a   Kumar, S ^a   Barber, T M ^a  

^a UNIVERSITY OF WARWICK   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

LUTEINIZING HORMONE; TESTOSTERONE;

BODY MASS; DISEASE ASSOCIATION; HUMAN; HYPOGONADOTROPIC HYPOGONADISM; HYPOPHYSIS GONAD SYSTEM; LUTEINIZING HORMONE RELEASE; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; PATHOGENESIS; PREVALENCE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; SEXUAL FUNCTION; SLEEP DISORDER; SYSTEMATIC REVIEW; TESTOSTERONE BLOOD LEVEL;

DIABETES MELLITUS, TYPE 2; HUMANS; HYPOGONADISM; MALE; OBESITY; SLEEP APNEA, OBSTRUCTIVE;

EID: 84872961206     PISSN: 03000664     EISSN: 13652265     Source Type: Journal    
DOI: 10.1111/cen.12092     Document Type: Review

References (66)

1. Isidori, A.M., Giannetta, E., Greco, E.A., et al,. (2005) Effects of testosterone on body composition, bone metabolism and serum lipid profile in middle-aged men: a meta-analysis. Clinical Endocrinology, 63, 280-293. (Pubitemid 41233445)
2. Dandona, P., &, Dhindsa, S., (2011) Update: hypogonadotropic hypogonadism in type 2 diabetes and obesity. The Journal of Clinical Endocrinology and Metabolism, 96, 2643-2651.
3. Yeap, B.B., Hyde, Z., Almeida, O.P., et al,. (2009) Lower testosterone levels predict incident stroke and transient ischemic attack in older men. The Journal of Clinical Endocrinology and Metabolism, 94, 2353-2359.
4. Ponikowska, B., Jankowska, E.A., Maj, J., et al,. (2010) Gonadal and adrenal androgen deficiencies as independent predictors of increased cardiovascular mortality in men with type II diabetes mellitus and stable coronary artery disease. International Journal of Cardiology, 143, 343-348.
5. Mammi, C., Calanchini, M., Antelmi, A., et al,. (2012) Androgens and adipose tissue in males: a complex and reciprocal interplay. International Journal of Endocrinology, 2012, 789653.
6. Hofstra, J., Loves, S., van Wageningen, B., et al,. (2008) High prevalence of hypogonadotropic hypogonadism in men referred for obesity treatment. The Netherlands Journal of Medicine, 66, 103-109. (Pubitemid 351447486)
7. Cohen, P.G., (1999) The hypogonadal-obesity cycle: role of aromatase in modulating the testosterone-estradiol shunt-a major factor in the genesis of morbid obesity. Medical Hypotheses, 52, 49-51.
8. Kapoor, D., Malkin, C.J., Channer, K.S., et al,. (2005) Androgens, insulin resistance and vascular disease in men. Clinical Endocrinology, 63, 239-250. (Pubitemid 41233438)
9. Dhindsa, S., Prabhakar, S., Sethi, M., et al,. (2004) Frequent occurrence of hypogonadotropic hypogonadism in type 2 diabetes. The Journal of Clinical Endocrinology and Metabolism, 89, 5462-5468. (Pubitemid 39518427)
10. Tomar, R., Dhindsa, S., Chaudhuri, A., et al,. (2006) Contrasting testosterone concentrations in type 1 and type 2 diabetes. Diabetes Care, 29, 1120-1122. (Pubitemid 44115257)
11. Fernandez-Balsells, M.M., Murad, M.H., Lane, M., et al,. (2010) Clinical review 1: adverse effects of testosterone therapy in adult men: a systematic review and meta-analysis. The Journal of Clinical Endocrinology and Metabolism, 95, 2560-2575.
12. Caminiti, G., Volterrani, M., Iellamo, F., et al,. (2009) Effect of long-acting testosterone treatment on functional exercise capacity, skeletal muscle performance, insulin resistance, and baroreflex sensitivity in elderly patients with chronic heart failure a double-blind, placebo-controlled, randomized study. Journal of the American College of Cardiology, 54, 919-927.
13. Haddad, R.M., Kennedy, C.C., Caples, S.M., et al,. (2007) Testosterone and cardiovascular risk in men: a systematic review and meta-analysis of randomized placebo-controlled trials. Mayo Clinic Proceedings, Mayo Clinic, 82, 29-39. (Pubitemid 46036319)
14. Jones, T.H., Arver, S., Behre, H.M., et al,. (2011) Testosterone replacement in hypogonadal men with type 2 diabetes and/or metabolic syndrome (the TIMES2 study). Diabetes Care, 34, 828-837.
15. Kalinchenko, S.Y., Tishova, Y.A., Mskhalaya, G.J., et al,. (2010) Effects of testosterone supplementation on markers of the metabolic syndrome and inflammation in hypogonadal men with the metabolic syndrome: the double-blinded placebo-controlled Moscow study. Clinical Endocrinology (Oxford), 73, 602-612.
16. Brand, J.S., Wareham, N.J., Dowsett, M., et al,. (2011) Associations of endogenous testosterone and SHBG with glycated haemoglobin in middle-aged and older men. Clinical Endocrinology, 74, 572-578.
17. Watanobe, H., &, Hayakawa, Y., (2003) Hypothalamic interleukin-1 beta and tumor necrosis factor-alpha, but not interleukin-6, mediate the endotoxin-induced suppression of the reproductive axis in rats. Endocrinology, 144, 4868-4875. (Pubitemid 37378401)
18. Dandona, P., Aljada, A., &, Bandyopadhyay, A., (2004) Inflammation: the link between insulin resistance, obesity and diabetes. Trends in Immunology, 25, 4-7. (Pubitemid 38032801)
19. Kapoor, D, Clarke, S., Stanworth, R., et al,. (2007) The effect of testosterone replacement therapy on adipocytokines and C-reactive protein in hypogonadal men with type 2 diabetes. European Journal of Endocrinology/European Federation of Endocrine Societies, 156, 595-602. (Pubitemid 46796527)
20. Hammoud, A.O., Carrell, D.T., Gibson, M., et al,. (2012) Updates on the relation of weight excess and reproductive function in men: sleep apnea as a new area of interest. Asian Journal of Andrology, 14, 77-81.
21. Saad, F., &, Gooren, L.J., (2011) The role of testosterone in the etiology and treatment of obesity, the metabolic syndrome, and diabetes mellitus type 2. Journal of Obesity 2011, 2011.
22. Dhindsa, S., Miller, M.G., McWhirter, C.L., et al,. (2010) Testosterone concentrations in diabetic and nondiabetic obese men. Diabetes Care, 33, 1186-1192.
23. Popkin, B.M., (2010) Recent dynamics suggest selected countries catching up to US obesity. The American Journal of Clinical Nutrition, 91, 284S-288S.
24. Seftel, A.D., (2006) Male hypogonadism. Part I: epidemiology of hypogonadism. International Journal of Impotence Research, 18, 115-120. (Pubitemid 43336474)
25. Seftel, A., (2006) Male hypogonadism. Part II: etiology, pathophysiology, and diagnosis. International Journal of Impotence Research, 18, 223-228.
26. Bhasin, S., Pencina, M., Jasuja, G.K., et al,. (2011) Reference ranges for testosterone in men generated using liquid chromatography tandem mass spectrometry in a community-based sample of healthy nonobese young men in the Framingham Heart Study and applied to three geographically distinct cohorts. The Journal of Clinical Endocrinology and Metabolism, 96, 2430-2439.
27. Wu, FC., Tajar, A., Beynon, J.M., et al,. (2010) Identification of late-onset hypogonadism in middle-aged and elderly men. The New England Journal of Medicine, 363, 123-135.
28. Vesper, H.W., Bhasin, S., Wang, C., et al,. (2009) Interlaboratory comparison study of serum total testosterone [corrected] measurements performed by mass spectrometry methods. Steroids, 74, 498-503.
29. Guay, A.T., Spark, R.F., Bansal, S., et al,. (2003) American association of clinical endocrinologists medical guidelines for clinical practice for the evaluation and treatment of male sexual dysfunction: a couple's problem-2003 update. Endocrine Practice: Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists, 9, 77-95.
30. Jungwirth, A., Giwercman, A., Tournaye, H., et al,. (2012) European association of urology guidelines on male infertility: the 2012 update. European Urology, 62, 324-332.
31. Pitteloud, N., Durrani, S., Raivio, T., et al,. (2010) Complex genetics in idiopathic hypogonadotropic hypogonadism. Frontiers of Hormone Research, 39, 142-153.
32. Bhasin, S., Cunningham, GR., Hayes, FJ., et al,. (2010) Testosterone therapy in men with androgen deficiency syndromes: an Endocrine Society clinical practice guideline. The Journal of Clinical Endocrinology and Metabolism, 95, 2536-2559.
33. Kapoor, D., Aldred, H., Clark, S., et al,. (2007) Clinical and biochemical assessment of hypogonadism in men with type 2 diabetes: correlations with bioavailable testosterone and visceral adiposity. Diabetes Care, 30, 911-917. (Pubitemid 46556586)
34. Mulligan, T., Frick, M.F., Zuraw, Q.C., et al,. (2006) Prevalence of hypogonadism in males aged at least 45 years: the HIM study. International Journal of Clinical Practice, 60, 762-769. (Pubitemid 43881152)
35. Pitteloud, N., Dwyer, A.A., DeCruz, S., et al,. (2008) The relative role of gonadal sex steroids and gonadotropin-releasing hormone pulse frequency in the regulation of follicle-stimulating hormone secretion in men. The Journal of Clinical Endocrinology and Metabolism, 93, 2686-2692. (Pubitemid 352008537)
36. Loves, S., Ruinemans-Koerts, J., &, de Boer, H., (2008) Letrozole once a week normalizes serum testosterone in obesity-related male hypogonadism. European Journal of Endocrinology/European Federation of Endocrine Societies, 158, 741-747. (Pubitemid 351639613)
37. Isidori, A.M., Caprio, M., Strollo, F., et al,. (1999) Leptin and androgens in male obesity: evidence for leptin contribution to reduced androgen levels. The Journal of Clinical Endocrinology and Metabolism, 84, 3673-3680. (Pubitemid 30645224)
38. Blouin, K., Boivin, A., &, Tchernof, A., (2008) Androgens and body fat distribution. The Journal of Steroid Biochemistry and Molecular Biology 108, 272-280. (Pubitemid 351179628)
39. Zumoff, B., Miller, L.K., &, Strain, G.W., (2003) Reversal of the hypogonadotropic hypogonadism of obese men by administration of the aromatase inhibitor testolactone. Metabolism: Clinical and Experimental, 52, 1126-1128. (Pubitemid 37203485)
40. Dandona, P., Dhindsa, S., Chaudhuri, A., et al,. (2008) Hypogonadotrophic hypogonadism in type 2 diabetes, obesity and the metabolic syndrome. Current Molecular Medicine 8, 816-828.
41. Ganesh, H.K., Vijaya Sarathi, H.A., George, J., et al,. (2009) Prevalence of hypogonadism in patients with type 2 diabetes mellitus in an Asian Indian study group. Endocrine Practice: Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists, 15, 513-520.
42. Gamba, M., &, Pralong, FP., (2006) Control of GnRH neuronal activity by metabolic factors: the role of leptin and insulin. Molecular and Cellular Endocrinology 254-255, 133-139. (Pubitemid 44063601)
43. Luboshitzky, R., Lavie, L., Shen-Orr, Z., et al,. (2005) Altered luteinizing hormone and testosterone secretion in middle-aged obese men with obstructive sleep apnea. Obesity Research, 13, 780-786.
44. Meczekalski, B., Podfigurna-Stopa, A., &, Genazzani, A.R., (2011) Why kisspeptin is such important for reproduction? Gynecological Endocrinology: The Official Journal of the International Society of Gynecological Endocrinology, 27, 8-13.
45. George, J.T., Millar, R.P., &, Anderson, R.A., (2010) Hypothesis: kisspeptin mediates male hypogonadism in obesity and type 2 diabetes. Neuroendocrinology, 91, 302-307.
46. Grossmann, M., Thomas, M.C., Panagiotopoulos, S., et al,. (2008) Low testosterone levels are common and associated with insulin resistance in men with diabetes. The Journal of Clinical Endocrinology and Metabolism, 93, 1834-1840. (Pubitemid 351656526)
47. Chandel, A., Dhindsa, S., Topiwala, S., et al,. (2008) Testosterone concentration in young patients with diabetes. Diabetes Care, 31, 2013-2017.
48. Yeap, B.B., Chubb, S.A., Hyde, Z., et al,. (2009) Lower serum testosterone is independently associated with insulin resistance in non-diabetic older men: the Health In Men Study. European journal of endocrinology / European Federation of Endocrine Societies, 161, 591-598.
49. Potenza, M., &, Shimshi, M., (2008) Male hypogonadism: The unrecognized cardiovascular risk factor. Journal of Clinical Lipidology 2, 71-78. (Pubitemid 351372948)
50. Li, C., Ford, E.S., Li, B., et al,. (2010) Association of testosterone and sex hormone-binding globulin with metabolic syndrome and insulin resistance in men. Diabetes Care, 33, 1618-1624.
51. Bruning, J.C., Gautam, D., Burks, D.J., et al,. (2000) Role of brain insulin receptor in control of body weight and reproduction. Science, 289, 2122-2125.
52. Tajar, A., Forti, G., O'Neill, T.W., et al,. (2010) Characteristics of secondary, primary, and compensated hypogonadism in aging men: evidence from the European Male Ageing Study. The Journal of Clinical Endocrinology and Metabolism, 95, 1810-1818.
53. Russell, S.H., Small, C.J., Stanley, S.A., et al,. (2001) The in vitro role of tumour necrosis factor-alpha and interleukin-6 in the hypothalamic-pituitary gonadal axis. Journal of Neuroendocrinology, 13, 296-301. (Pubitemid 32170995)
54. Bhatia, V., Chaudhuri, A., Tomar, R., et al,. (2006) Low testosterone and high C-reactive protein concentrations predict low hematocrit in type 2 diabetes. Diabetes Care, 29, 2289-2294. (Pubitemid 44899867)
55. Ghanim, H., Aljada, A., Daoud, N., et al,. (2007) Role of inflammatory mediators in the suppression of insulin receptor phosphorylation in circulating mononuclear cells of obese subjects. Diabetologia, 50, 278-285.
56. Ding, E.L., Song, Y., Manson, J.E., et al,. (2009) Sex hormone-binding globulin and risk of type 2 diabetes in women and men. The New England Journal of Medicine, 361, 1152-1163.
57. Perry, J.R., Weedon, M.N., Langenberg, C., et al,. (2010) Genetic evidence that raised sex hormone binding globulin (SHBG) levels reduce the risk of type 2 diabetes. Human Molecular Genetics, 19, 535-544.
58. Laaksonen, D.E., Niskanen, L., Punnonen, K., et al,. (2004) Testosterone and sex hormone-binding globulin predict the metabolic syndrome and diabetes in middle-aged men. Diabetes Care, 27, 1036-1041. (Pubitemid 38579762)
59. Katabami, T., Kato, H., Asahina, T., et al,. (2010) Serum free testosterone and metabolic syndrome in Japanese men. Endocrine Journal, 57, 533-539.
60. Pitteloud, N., Hardin, M., Dwyer, A.A., et al,. (2005) Increasing insulin resistance is associated with a decrease in Leydig cell testosterone secretion in men. The Journal of Clinical Endocrinology and Metabolism, 90, 2636-2641. (Pubitemid 40686302)
61. Andersen, M.L., &, Tufik, S., (2008) The effects of testosterone on sleep and sleep-disordered breathing in men: its bidirectional interaction with erectile function. Sleep Medicine Reviews, 12, 365-379.
62. Schafer, H., Pauleit, D., Sudhop, T., et al,. (2002) Body fat distribution, serum leptin, and cardiovascular risk factors in men with obstructive sleep apnea. Chest, 122, 829-839.
63. Hoyos, C.M., Killick, R., Yee, B.J., et al,. (2012) Effects of testosterone therapy on sleep and breathing in obese men with severe obstructive sleep apnea: a randomised placebo-controlled trial. Clinical Endocrinology (Oxford), 77, 599-607.
64. Molina, F.D., Suman, M., Carvalho, T.B., et al,. (2011) Evaluation of testosterone serum levels in patients with obstructive sleep apnea syndrome. Brazilian Journal of Otorhinolaryngology, 77, 88-95.
65. Behan, M., Zabka, A.G., Thomas, C.F., et al,. (2003) Sex steroid hormones and the neural control of breathing. Respiratory Physiology & Neurobiology, 136, 249-263. (Pubitemid 36809011)
66. Hammoud, A.O., Walker, J.M., Gibson, M., et al,. (2011) Sleep apnea, reproductive hormones and quality of sexual life in severely obese men. Obesity, 19, 1118-1123.